CETIRIZINE HYDROCHLORIDE- cetirizine hydrochloride tablet 
Torrent Pharmaceuticals Limited

----------

Cetirizine Hydrochloride Tablets

Drug Facts:

Active ingredient (in each tablet)   

Cetirizine HCl 10 mg

Purpose: Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

Warnings

Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.

When using this product

  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding:

  • If breast-feeding: not recommended
  • If pregnant: ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

adults and children 6 years
  and over
  one 10 mg tablet once daily; do not take more 
  than one 10 mg tablet in 24 hours. A 5 mg 
  product may be appropriate for less severe   
symptoms.
  adults 65 years and over
  ask a doctor
  children under 6 years of age
  ask a doctor
  consumers with liver or kidney
  disease
  ask a doctor

Other information

  • store between 20° to 25°C (68° to 77°F)

Inactive ingredients colloidal silicon dioxide, corn starch, hypromellose, lactose monohydrate, magnesium stearate, polyethylene glycol, povidone, talc, titanium dioxide

Questions or comments?

call 1-269-544-2299 weekdays

Logo

Manufactured by :

TORRENT PHARMACEUTICALS LTD.

Indrad-382 721, Dist. Mehsana, INDIA.

PRINCIPAL DISPLAY PANEL

NDC 13668-030-05

Cetirizine HCl Tablets 10 mg

Antihistamine

Allergy

Indoor & Outdoor Allergies

24 Hour Relief of

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

500 Tablets 10 mg each

Tamper Evident:

Do not use if imprinted inner safety seal is torn or missing.

Label
CETIRIZINE HYDROCHLORIDE 
cetirizine hydrochloride tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13668-030
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24) CETIRIZINE HYDROCHLORIDE10 mg
Inactive Ingredients
Ingredient NameStrength
STARCH, CORN (UNII: O8232NY3SJ)  
HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
POVIDONE K30 (UNII: U725QWY32X)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
Colorwhite (white to off white) Scoreno score
ShapeROUND (rounded-off,rectangular shaped, film coated tablet) Size9mm
FlavorImprint Code 10;30
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13668-030-3030 in 1 BOTTLE; Type 0: Not a Combination Product04/15/201004/15/2010
2NDC:13668-030-01100 in 1 BOTTLE; Type 0: Not a Combination Product04/15/201004/15/2010
3NDC:13668-030-25250 in 1 BOTTLE; Type 0: Not a Combination Product04/15/201004/15/2010
4NDC:13668-030-05500 in 1 BOTTLE; Type 0: Not a Combination Product04/15/201004/15/2010
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07919104/15/201004/15/2010
Labeler - Torrent Pharmaceuticals Limited (916488547)
Registrant - Torrent Pharma, Inc. (790033935)
Establishment
NameAddressID/FEIBusiness Operations
Torrent Pharmaceuticals Limited916488547manufacture(13668-030)

Revised: 10/2019
 
Torrent Pharmaceuticals Limited